Keith Cooper

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 2

Top Topics

Epstein Barr Virus

Chronic Rhinosinusitis

Diffuse Large B Cell Lymphoma

Clinical Evaluation

Top Venues

PharmacoEconomics

SHTAC

This page only lists publications with an associated author ORCID identifier.

Affiliation History

SHTAC

United Kingdom

Senior Research Fellow :: SHTAC

Publications

Keith Cooper, Emma Maund, Marcia Tomie Takahashi, Jonathan Shepherd
Using Cure Modelling for Cost Effectiveness in the NICE Technology Appraisal of Polatuzumab Vedotin in Combination for Untreated Diffuse Large B Cell Lymphoma: An External Assessment Group Perspective. PharmacoEconomics (2024)
Keith Cooper, Geoff Frampton, Petra Harris, Micah Rose, Maria Chorozoglou, Karen Pickett
Reslizumab for Treating Asthma with Elevated Blood Eosinophils Inadequately Controlled by Inhaled Corticosteroids: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics 36 (5) (2019)